Rechon Life Science Employs Scalable Serialization/Aggregation

Sweden pharmaceutical maker and CMO partners adds Adents software on its printing equipment to offer its customers scalable track and trace.

Rechon Life Science AB, a Sweden-based pharmaceuticals developer and contract manufacturer, has partnered with Adents, a provider of serialization and aggregation software, to offer its customers scalable track and trace that complements Rechon’s pharmaceuticals production and packaging services.

In choosing Adents, Rechon addresses compliance with several looming serialization mandates, including the European Union Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act. Eventually, all track and trace applications will interface with Rechon’s Enterprise Resource Planning (ERP) system.

To meet its evolving needs, Rechon required a software solution that was flexible enough to change line configurations per client needs, able to generate and securely import/export unique serial numbers, and offer a workable pricing model. Rechon also sought to use its existing infrastructure to incorporate this serialization plan. Rechon has close ties with ACT-Logimark, a Sweden-based printing equipment provider and systems integration specialist.

Maria Wingren, Manager Projects & Validation, says: “As a company that manufactures and packages pharmaceutical products for leading pharmaceutical companies around the world, Rechon requires regulatory solutions that address a wide array of both customer and internal needs. In Adents Pharma Suite software, we believe we’ve found an easy to use, standardized solution that meets the complexities of current and future track-and-trace mandates—a flexible, scalable approach that works within our existing hardware and various, client-specific line configurations.”

Rechon offers a comprehensive range of pharmaceutical services, including the preparation, filling, packaging and distribution of commercial products as well as clinical trial supplies. The company’s cGMP contract pharmaceutical development services include process and analytical development; manufacturing, supplies and services for clinical trials; stability studies; storage and distribution and Qualified Person (QP) release services.

For Adents, the deal represents further geographical expansion of its widening global customer base, including its first foray into Scandinavia. According to Christophe Devins, CEO and Founding Partner of Adents: “Our partnership with Rechon is far more than a typical vendor-customer relationship. It establishes an ecosystem of system integrators capable of implementing serialization solutions expediently and on a grand scale. This deal also brings together a consortium of experts capable of addressing track-and-trace issues from a holistic view—the effective marriage of software, hardware and line integration.”

More in Home